BloodThinnerHelp.com reports on the details of Xarelto and Xa Inhibitor dangers. Xarelto is a prescription blood thinner that uses rivaroxaban. It is a new class of blood thinner, known as an Xa Inhibitor, which means that it works differently from older blood thinners like Warfarin. Xa Inhibitors do not require the regular monitoring, dosage adjustments, and dietary restrictions that older blood thinners do. They are known as a “one-size-fits-all,” revolutionary drug, that is able to provide users with more freedom and convenience. The same things that initially helped the drug’s popularity, however, also pose increased risks.
Xarelto is manufactured by Bayer AG and Janssen Pharmaceuticals, a division of Johnson & Johnson. The drug gained approval from the United States Food and Drug Administration in 2001, and was available for purchase that same year. Since this initial release, advertising has focused on the conveniences associated with the new drug. According to allegations in recent lawsuits, however, these advertisements neglected to properly illustrate the significant dangers associated with the drug as well.
Xarelto is considered exceptionally dangerous by many due to the fact that it has no antidote. Because it is an Xa Inhibitor, it is made up of different chemicals than traditional blood thinners. This means that if a patient using Xarelto suddenly develops unstoppable bleeding, physicians have no way to reverse the drug’s effects and stop the bleed. When patients using Warfarin or other similar, older anticoagulants suffer from bleeding issues, doctors are able to use a vitamin K treatment to counteract the drug and allow their blood to clot. Xarelto does not respond to vitamin K. If someone is significantly bleeding and they have Xarelto in their body, doctors have to resort to life-saving measures, such as blood transfusions.
Recently, multiple studies have shown links between Xarelto and uncontrollable internal bleeding events or significant blood clots, which often lead to serious health issues such as brain or gastrointestinal bleeds, hematoma, and pulmonary embolism. In light of these warnings and the fact that Xarelto has no antidote, the drug has two “black box” warnings from the FDA attached to it. Black Box warnings are the most strict warning the FDA can give a drug before pulling it off the market.
Across the United States, people are now filing lawsuits against the drug and its manufacturers. Attorney Marc Goldich is currently working to ensure that everyone who has suffered health issues after using Xarelto is able to look into their legal rights. He provides free consultations, so that individuals are able to evaluate whether they may be able to seek compensation.
For questions concerning this topic or to obtain additional information, please contact Marc Goldich, Esq. at 866-425-8902.
###
Contact BloodThinnerHelp.com:
Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.
